All Heidelberg University Hospital articles
-
NewsMonoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.
-
NewsMechanisms may be used to lure viruses into a trap
Researchers have described previously unknown mechanisms of viral penetration by the Influenza A and Ebola viruses, which could lead to new approaches to prevent infections.
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
